Luhan Yang, Ph.D.

Dr. Yang is leading the scientific strategies and efforts at eGenesis. She previously developed the highly programmable genome-engineering tool, CRISPR-Cas9, for use in mammalian cells, and pioneered the first isogenic human stem cell lines to model human diseases at the tissue level. She was named among the “30 Under 30” in Science and Healthcare by Forbes Magazine (2014), was a laureate of the “Young Entrepreneur Initiative” competition (2014) and “Young Global Leader” by World Economic Forum. Dr. Yang holds B.S. degrees in Biology and Psychology from Peking University and a Ph.D. in Human Biology and Translational Medicine from Harvard Medical School.